{"name":"iRhythm Technologies, Inc.","slug":"irhythm","ticker":"IRTC","exchange":"NASDAQ","domain":"irhythmtech.com","description":"iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which ","hq":"San Francisco, CA","founded":0,"employees":"2400","ceo":"Quentin Blackford","sector":"MedTech / Digital Health / Cardiac Monitoring","stockPrice":121.68,"stockChange":3.05,"stockChangePercent":2.57,"marketCap":"$3.9B","metrics":{"revenue":747138000,"revenueGrowth":27.1,"grossMargin":70.6,"rdSpend":60244000,"netIncome":-44551000,"cash":583763008,"dividendYield":0,"peRatio":145.5,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"earnings","headline":"iRhythm Technologies Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"iRhythm reported revenue of $73.1 million for the fourth quarter of 2023, a 24% increase from the same period in 2022.","drugName":"","sentiment":"positive"},{"date":"2023-11-15","type":"deal","headline":"iRhythm Technologies Announces Collaboration with Medtronic to Develop Next-Generation Cardiac Monitoring Solutions","summary":"iRhythm partnered with Medtronic to develop new cardiac monitoring solutions, expanding its reach in the digital health space.","drugName":"","sentiment":"positive"},{"date":"2023-08-01","type":"regulatory","headline":"iRhythm Technologies Receives FDA Clearance for Zio Patch","summary":"iRhythm received FDA clearance for its Zio patch, expanding its product portfolio in the cardiac monitoring space.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxNWTNJY3I0VkFZUkpvWmFhaTByVkRNc2NNNlZlaEZUcTRBSnpRRzdtUUVkekp5VVJuQWxqVDlHTjltRzRxMjZtRmtRU1E2S1Q0cHFoeHkxYWtRQlBTNGRhcTBJQ29oMmgyc1lVQzBCZDR1UVduWmF4UmpiMWxQNG5nRFZaaWxpU2gyTUlzM3VHbDlhSjRmOXljM0Q1TkVPQjktYlpUUU1qU2lVa1gwS0NYX1pTXy15RUdXR0FkR0I4alFqTFlDOVR3aFRnQk1WZWJya3djZ0laZllSVFIyNjJkT09zd0M?oc=5","date":"2026-04-06","type":"pipeline","source":"ACCESS Newswire","summary":"Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Connect - ACCESS Newswire","headline":"Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Con","sentiment":"neutral"},{"date":"2026-04-01","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNMzhyMmRPRGQ4REQ2RjV2Y0ZFRFlYYTlhdnZsQXVaYXkzM0lJLU5HWXFFNEF1NG56RGxzSldQRkd0NlBRcVBVZ1diZEEwQ20xNnNMWEk0dHlXSEdCWkJCWk92eFI3WFdIbmgxSWFWRDFPSENfNmpxTk5xTGpWUUFZSGx3Q3pGNm5FZ0IwTzNUd3BsV3A2QmdGOGpTRVRDTEJwTXFvNDMzbmJUaHh5Y3BGaEQ2TTJJS0FmZzkyOFhBRC1XRkJoY3VfWGtSOFk?oc=5","date":"2026-03-19","type":"pipeline","source":"MarketBeat","summary":"Tudor Investment Corp ET AL Takes Position in iRhythm Technologies $IRTC - MarketBeat","headline":"Tudor Investment Corp ET AL Takes Position in iRhythm Technologies $IRTC","sentiment":"neutral"},{"date":"2026-03-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQdVpwSnNlQS12VnVCaVF3R1V6NklxNFRuQUdiMjZsbVc3RGRDbTlrZ2E1cE8wczBnbmdQSlBYTk9KLW5COWUwRVVrSWV3S2ZJTnJjVDNkam9mTE1kVWlsRVM2d1FFODNWZ3gyWVhZZjhiSG5KYkQySWlDM2ZYeTVBcEI2U2JxaGdvTEJnWlZaTkY4NlZRRkZFSGdYOW53eTFNS0txZ3FvSDdGSlZhb1FLdjd2M1J2cjlP?oc=5","date":"2026-01-13","type":"pipeline","source":"Investing.com","summary":"Intel and Visa among market cap stock movers on Tuesday - Investing.com","headline":"Intel and Visa among market cap stock movers on Tuesday","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQZndrRlVFS2ZJSXczVFpJWWl0X3d0R1dDcE9iTVVjblZTZjlidmtEb1MwdlZEWkZMSzg3MWd6TmJ3U3d0VXpmT2ZXOXpKMFpvcG5fd2IwXzhmeWE2QlNNN2pBNlEtNy1NY1o5Vzlld213LUpoaW9yQllxVVBpMWZpRFMyTm9PSkNqTDhrX0RUd251Y3dSdlZaSVAxU21QYTdpNjhOZ2Y3a093X2RKOGxoZVZqVFFvNDQ?oc=5","date":"2026-01-13","type":"pipeline","source":"Investing.com Canada","summary":"Intel and Visa among market cap stock movers on Tuesday By Investing.com - Investing.com Canada","headline":"Intel and Visa among market cap stock movers on Tuesday By Investing.com","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPYVlBWmllZE5ReF9Ud1A3QUlFN3JpMnBuR19OMEgtWDl1c2xpb2FrYlVHdGFJZ2haWWx0LUVkdDVkSW94Qm01RWQ0NjNLT1hrSjZSbFlURkd0TEFMWUVrZVFnMlowdm4xbVFNX2FfaWxLenZwTVhjczZtNFQ0elRvTEJiUU43QVpvNVRMdHRucWkxUQ?oc=5","date":"2026-01-12","type":"pipeline","source":"Investor's Business Daily","summary":"JPM Kicks Off With Alnylam In the Red; But Others Surge - Investor's Business Daily","headline":"JPM Kicks Off With Alnylam In the Red; But Others Surge - Investor's Business Daily","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxNaGpqRVp3cFdLZU1YNEpvWWdtUW9FN0xEN3UzR0FibTBxbWRpdnZsZDV5aWttNDNrZ1U0YmdHdWpNcjlONE1iclZQYlBFdWptX3U1RmFUM00wUGJ0SjRLeDkwZXlxemlNRjBMRU5kUkxXaWFIM1JicWt4ZDBwd1V0SUFxa2tqT2VUb3NWQmJXUmdIVENtdjRuMlluVnZXZDNTTUE3ZXAxeXBaeW1EVjNNOER6VTNsdkQ0NlFVaVBSaHpBOUhmcEdPQkppaVlPMFk?oc=5","date":"2026-01-07","type":"pipeline","source":"PR Newswire","summary":"Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm - PR Newswire","headline":"Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxQVFd1Ukl4bkxuWlBlWTcwLUl6dWNjWkI3bmJJOFNQUDBzZXRxWFJTc0xnekNVc05lemhiNVAxMkFWYkRUR2FlVW96TTJPRWxoVGh2SDdVbTB0ZG4xeURPSjFoQVRaVGk2NnJwQmZLV3pyNnV2bzNMRmV4LWtTckNzU2huYWRTdTBFd2hDZDBUTFhFb1JTUklDWENLUXIxa3JDZGFsRGxHZGxyVWtJSmtLaGQtb2tDcWVCRnVPd3ZzZktfZDdIRmdtaWdXVHQ2SHdFT25z?oc=5","date":"2025-12-05","type":"pipeline","source":"FinancialContent","summary":"1 Mooning Stock with Promising Prospects and 2 Facing Challenges - FinancialContent","headline":"1 Mooning Stock with Promising Prospects and 2 Facing Challenges","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxQSGJyYmx4Y1B3QU9lZ2VSNmZ1OENuRW5DLTNyTTRKOVFzUUxUdWlVRjdERDJIc21oZzh3N0tQek0yMDJPQ19lc0FPUkZrcVlEX29yWnR6R0VHWmpXaFlMUDlUS0lDcGxuelprQVJBTk5jLVlnUF83ZDlmR2gxOU8zcmZoREo2WEFTWU5iOGlnNjl6dUh2eDg1OE9wdXBfckkwMm1Ha1ExZVp4ZzlzMmowZUctamhzbmN1S1B5ZFpDSE5Oc01qRnNOZ0Eyc0VkM1NFcG1ZMXlJdkpCQllPYlBnSk11SQ?oc=5","date":"2025-10-02","type":"pipeline","source":"The Globe and Mail","summary":"2 Healthcare Stocks to Research Further and 1 Facing Challenges - The Globe and Mail","headline":"2 Healthcare Stocks to Research Further and 1 Facing Challenges","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxOVldyUHBXdk1tLW53SUIzcnJ2bW1MSjhjOUQ2UVJfd0RfbkZtNFJGU0ZsS1BNaXJWcUplM2dIVk1FcENkbkEyWWF3SjRETy1oWHFueDViNkVGdXRDS3EtZXAyRjFsVDd3bUltbjJDbXRDQzRndzhBdHRYSVBhTmRfOTY3ajhIQkFsN0k5U1g5MDUxUnpWY1l3aG9ZN0kyakhxWXBDZ2JFMnlHNWt0YjdfbXJWV2pEMjhRUTR2SGx0V1ZpWWFqSDZsQVNNMlRvLUpaQUFaSjdBc3UxR2laeUFQaHd3U183SU9icW5oS00zbEZYM3lLS051Q3BXRXlyRGtFZFh0dGp1OE82VDkxaVpHd0pR?oc=5","date":"2025-06-17","type":"pipeline","source":"globenewswire.com","summary":"Robbins LLP Informs iRhythm Technologies, Inc. (IRTC) Investors That the Class Action Beat the Motion to Dismiss - globenewswire.com","headline":"Robbins LLP Informs iRhythm Technologies, Inc. (IRTC) Investors That the Class Action Beat the Motion to Dismiss","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNUHRldndrem5rYzFqYXFybFZNcmFSTjhydHZ3djIwMFNscXlFX012aHAwcWlqY19iT3puSlYzTnU0VDZQSGR1Z3lzLU8wQzFzc0ItVW83NzdhWEJaaWczc3pob3Yta3JXc3l1M2RHM1IxLTRQSjE5cWh4REMwVW5XLXJpZWhBS2g5SG4yUXgzT19IRWpxSWhKRTdBQUlDV2hSQ2xXSVBRSnhGY1N3OEQ3RFp1ZU8wQQ?oc=5","date":"2025-01-13","type":"earnings","source":"Stock Titan","summary":"iRhythm Surpasses 2024 Revenue Targets, Projects Strong 2025 Growth with Record Zio Monitor Adoption - Stock Titan","headline":"iRhythm Surpasses 2024 Revenue Targets, Projects Strong 2025 Growth with Record Zio Monitor Adoption","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOVXpqQnM1aVFzNmpnWWZUcHhPWDB4Q1I0S0dxNUtEYTczb0dndVNGcFN0YkpMTllGdy1fek9EZnhUNVFYNnFSUDFJdFoyUHVsUnJabERBU2dYRjFoNkFkR3hFZnlkQTRYZ2lBNG5HdGFwaGhIMzlMN21DbUZvNWhhY05rc0ZuMDlLUXUxczc1ZjZ2TTlHMFdwVnludEU?oc=5","date":"2024-11-18","type":"pipeline","source":"Quiver Quantitative","summary":"ROBO Global Healthcare Technology and Innovation ETF Holdings - Quiver Quantitative","headline":"ROBO Global Healthcare Technology and Innovation ETF Holdings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQa3VmdlQyRi1kRDlDYk5MQlhjVlA4ZDJlNVJCcEdlQnFaNWtIVURHMTItV0VPS2FuZDdBbW8zTlJ1dGNKWG5NY0VERzY4cEF3ZHJvTjI2OWJtdEt6d2Zrck9Xdm9LQUQ1VFVfaVNWdmZ2aU15VzZCbGNXUElsSlRqWFA5VzNtUzEwb3VLZVJKRTVYZUFZ?oc=5","date":"2023-07-13","type":"regulatory","source":"Seeking Alpha","summary":"iRhythm Technologies: Unpacking The FDA Warning Letter (NASDAQ:IRTC) - Seeking Alpha","headline":"iRhythm Technologies: Unpacking The FDA Warning Letter (NASDAQ:IRTC)","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Boston Scientific","Medtronic","Abbott Laboratories"],"therapeuticFocus":["Cardiac Monitoring","Digital Health"],"financials":{"source":"sec_edgar+yahoo","revenue":747138000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":747138000,"period":"2025-12-31"},{"value":591839000,"period":"2024-12-31"},{"value":591839000,"period":"2024-12-31"},{"value":492681000,"period":"2023-12-31"},{"value":492681000,"period":"2023-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":60244000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-44551000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":1020042000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":2400,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":121.68,"previousClose":118.63,"fiftyTwoWeekHigh":212,"fiftyTwoWeekLow":93.66,"fiftyTwoWeekRange":"93.66 - 212.0","fiftyDayAverage":134.67,"twoHundredDayAverage":159.39,"beta":1.18,"enterpriseValue":3981158144,"forwardPE":145.5,"priceToBook":25.73,"priceToSales":5.26,"enterpriseToRevenue":5.33,"enterpriseToEbitda":-130.24,"pegRatio":0,"ebitda":-30568000,"ebitdaMargin":-4.1,"freeCashflow":71667504,"operatingCashflow":80863000,"totalDebt":731184000,"debtToEquity":478.7,"currentRatio":4.63,"returnOnAssets":-2.4,"returnOnEquity":-36.6,"analystRating":"1.3 - Strong Buy","recommendationKey":"strong_buy","numberOfAnalysts":14,"targetMeanPrice":208.57,"targetHighPrice":254,"targetLowPrice":170,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":1.1,"institutionHeldPercent":114.3,"sharesOutstanding":32316760,"floatShares":30244933,"sharesShort":2890311,"shortRatio":3.91,"shortPercentOfFloat":8.9,"epsTrailing":-1.39,"epsForward":0.84,"revenuePerShare":23.34,"bookValue":4.73,"officers":[{"age":46,"name":"Mr. Quentin S. Blackford","title":"President, CEO & Director"},{"age":42,"name":"Mr. Daniel G. Wilson","title":"CFO & Principal Financial Officer"},{"age":50,"name":"Dr. Minang P. Turakhia M.D., M.S.","title":"Chief Medical & Scientific Officer and Executive VP of Advanced Technologies"},{"age":46,"name":"Mr. Patrick Michael Murphy J.D.","title":"Chief Business & Legal Officer"},{"age":42,"name":"Mr. Chad M. Patterson","title":"Chief Commercial and Product Officer"},{"age":49,"name":"Mr. Mervin  Smith","title":"Executive Vice President of Business Operations"},{"age":52,"name":"Mr. Marc  Rosenbaum","title":"Senior VP of Finance & Chief Accounting Officer"},{"age":55,"name":"Mr. Brian  Lawrence","title":"Executive VP & CTO"}],"industry":"Medical Devices","irWebsite":"","website":"https://www.irhythmtech.com","phone":"415 632 5700"}}